Cargando…
Bone Morphogenetic Protein Type I Receptor Antagonists Decrease Growth and Induce Cell Death of Lung Cancer Cell Lines
Bone morphogenetic proteins (BMPs) are highly conserved morphogens that are essential for normal development. BMP-2 is highly expressed in the majority of non-small cell lung carcinomas (NSCLC) but not in normal lung tissue or benign lung tumors. The effects of the BMP signaling cascade on the growt...
Autores principales: | Langenfeld, Elaine, Hong, Charles C., Lanke, Gandhi, Langenfeld, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625205/ https://www.ncbi.nlm.nih.gov/pubmed/23593444 http://dx.doi.org/10.1371/journal.pone.0061256 |
Ejemplares similares
-
Small molecule antagonist of the bone morphogenetic protein type I receptors suppresses growth and expression of Id1 and Id3 in lung cancer cells expressing Oct4 or nestin
por: Langenfeld, Elaine, et al.
Publicado: (2013) -
Bone morphogenetic protein receptor 2 inhibition destabilizes microtubules promoting the activation of lysosomes and cell death of lung cancer cells
por: Mondal, Arindam, et al.
Publicado: (2021) -
Inhibition of BMP and of TGFβ receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death
por: Augeri, Dave J., et al.
Publicado: (2016) -
Targeting bone morphogenetic protein receptor 2 sensitizes lung cancer cells to TRAIL by increasing cytosolic Smac/DIABLO and the downregulation of X-linked inhibitor of apoptosis protein
por: NeMoyer, Rachel, et al.
Publicado: (2019) -
Bone morphogenetic protein inhibitors and mitochondria targeting agents synergistically induce apoptosis-inducing factor (AIF) caspase-independent cell death in lung cancer cells
por: Mondal, Arindam, et al.
Publicado: (2022)